Sphingosine 1-phosphate as a therapeutic agent Journal Article


Authors: Spiegel, S.; Kolesnick, R.
Article Title: Sphingosine 1-phosphate as a therapeutic agent
Abstract: The bioactive sphingolipid metabolite sphingosine-l-phosphate (W), formed by activation of sphingosine kinase in response to diverse stimuli, is an important lipid mediator that has novel dual actions - both inside and outside of cells. S1P is the ligand for a family of five G protein-coupled receptors. Activation of these GPCRs by S1P or dihydro-SlP regulates diverse processes, including cell migration, angiogenesis, vascular maturation, heart development, and neurite retraction. There is also abundant evidence that S1P can function as a second messenger important for regulation of calcium homeostasis, cell growth, and suppression of apoptosis. In many cases, the intracellular level of S1P and ceramide, another important sphingolipid metabolite associated with cell death and cell growth arrest, coordinately determine cell fate. Changes in S1P and ceramide have been implicated in a number of pathological conditions in which apoptosis plays an important role. Importantly, radiation-induced oocyte loss in adult female mice, the event that drives premature ovarian failure and infertility in female cancer patients, was completely prevented by in vivo therapy with S1P. Understanding the biosynthesis, metabolism and functions of S1P can uncover new targets for the pharmaceutical and therapeutic applications of S1P.
Keywords: apoptosis; ceramide; saccharomyces-cerevisiae; protein-kinase-c; molecular-cloning; signal-transduction; calcium mobilization; functional-characterization; gpcr; programmed cell-death; sphingolipid metabolism; sphingolipid metabolites; spingosine-1-phosphate; leukemic hl-60 cells; sphingosine-1-phosphate lyase
Journal Title: Leukemia
Volume: 16
Issue: 9
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 2002-09-01
Start Page: 1596
End Page: 1602
Language: English
ACCESSION: WOS:000178019200004
DOI: 10.1038/sj.leu.2402611
PROVIDER: wos
PUBMED: 12200669
Notes: Review -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard N Kolesnick
    299 Kolesnick